商务合作
动脉网APP
可切换为仅中文
LADENBURG, Germany, July 8, 2024 /PRNewswire/ -- New4med GmbH, a German startup focused on innovative spinal treatments, announces the successful European market launch of its novel Basivertebral Nerve Ablation (BVNA) therapy.
拉登堡,德国,2024年7月8日/PRNewswire/--New4med GmbH,一家专注于创新脊柱治疗的德国初创公司,宣布其新型基底神经消融(BVNA)疗法在欧洲市场成功推出。
BVNA is a treatment for vertebrogenic pain, a type of chronic low back pain associated with bony lesions on the vertebral endplates. The system, approved in Europe, is a minimally invasive, implant-free procedure that can be performed on both inpatient and outpatient bases. It uses targeted radiofrequency energy to block the Nervus basivertebralis from transmitting pain signals to the brain, aiming to improve function and provide sustainable relief..
。该系统已在欧洲获得批准,是一种微创无植入手术,可在住院和门诊患者中进行。它使用有针对性的射频能量来阻止基底神经向大脑传递疼痛信号,旨在改善功能并提供可持续的缓解。。
'By offering BVNA to physicians, we are providing access to this unique treatment for people with vertebrogenic pain in Europe for the first time,' said Daniel Seifert, Shareholder and designated CEO of New4med. 'Our goal is to make this high-growth therapeutic option available to a broad population of people with chronic low back pain.'.
New4med股东兼指定首席执行官丹尼尔·塞弗特(DanielSeifert)说,通过向医生提供BVNA,我们首次为欧洲椎源性疼痛患者提供了这种独特的治疗方法我们的目标是为广大慢性腰痛患者提供这种高增长的治疗选择。”。
'The revolutionary Basivertebral Nerve Ablation has tremendous potential to help even more people living with chronic pain,' said Prof. Robert Pflugmacher, Mechernich. 'Access to this form of therapy now significantly enhances our treatment spectrum in the field of interventional chronic pain management.' comments Prof.
Mechernich教授罗伯特·普夫卢格马赫(RobertPflugmacher)说,革命性的椎基底神经消融术具有巨大的潜力,可以帮助更多患有慢性疼痛的人现在,获得这种形式的治疗可以大大提高我们在介入性慢性疼痛管理领域的治疗范围。”评论教授。
Andreas Kurth, a pioneer in the treatment of spinal metastasis with RF technology..
Andreas Kurth是射频技术治疗脊柱转移瘤的先驱。。
'We will continue to invest in developing our infrastructure to ensure the broadest possible market access and to meet the growing demand for this treatment.' explained Eric Schaber, Shareholder and Strategy Consultant. 'This launch is the beginning of a series of new unique extremely innovative approaches that have the chance to revolutionize the current treatment options in spinal surgery' adds Eric Schaber..
“我们将继续投资发展基础设施,以确保尽可能广泛的市场准入,并满足对这种治疗日益增长的需求。”股东兼战略顾问埃里克·沙伯解释道埃里克·沙伯(EricSchaber)补充道:“这次发布是一系列独特且极具创新性的新方法的开始,这些方法有机会彻底改变脊柱外科目前的治疗选择。”。。
About New4med
关于New4med
New4med GmbH is a german medtech company specializing in the development and distribution of innovative products and procedures in spinal surgery. The product range aims to treat chronic back pain in the spine, improving patients' quality of life sustainably. New4med's experienced team consists of professionals from the medtech industry who bring their expertise and passion for innovation to the development and distribution of their products.
New4med GmbH是一家德国医学技术公司,专业从事脊柱外科创新产品和程序的开发和销售。该产品系列旨在治疗脊柱慢性背痛,可持续地提高患者的生活质量。New4med经验丰富的团队由来自医疗技术行业的专业人士组成,他们将专业知识和创新热情带入产品的开发和分销。
New4med prides itself on improving the quality of life for millions of people worldwide..
New4med以提高全球数百万人的生活质量而自豪。。
For more information, visit our website at www.new4med.com.
有关更多信息,请访问我们的网站www.new4med.com。
Contact
联系人
Daniel Seifert
丹尼尔·塞弗特
d.seifert@new4med.com
d.seifert@new4med.com
+49 174 – 666 66 47
+49 174 – 666 66 47
Photo - https://mma.prnewswire.com/media/2454767/New4Med.jpg
Photo - https://mma.prnewswire.com/media/2454767/New4Med.jpg
Logo - https://mma.prnewswire.com/media/2454766/New4Med_Logo.jpg
标志https://mma.prnewswire.com/media/2454766/New4Med_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/new4med-gmbh-announces-first-cases-of-its-novel-basivertebral-nerve-ablation-bvna-302189954.html
查看原始内容以下载多媒体:https://www.prnewswire.com/news-releases/new4med-gmbh-announces-first-cases-of-its-novel-basivertebral-nerve-ablation-bvna-302189954.html
SOURCE New4Med
源New4Med